The page is the record's research on the issuer — no analyst, no rating, no view.

Sernova Biotherapeutics Inc. (SVA) — research page

CA · ca-cm-kg/TSX/SVA · as of 2026-11-06

Identity and listing

Sernova Biotherapeutics Inc. is listed on the TSX under ticker SVA. ISIN CA81752F1062; LEI not on the record (ISIN not in the GLEIF ISIN-to-LEI mapping file). Security type: Corporate. Segment: not on the record. Sector: Life Sciences. Jurisdiction: not on the record (none found). Status: listed, not halted.

fieldvaluesource · read date
nameSernova Biotherapeutics Inc.source · 2026-11-06
exchangeTSXsource · 2026-11-06
tickerSVAsource · 2026-11-06
ISINCA81752F1062source · 2026-11-06
LEInot on the record
security typeCorporatesource · 2026-11-06
segmentnot on the record
sectorLife Sciencessource · 2026-11-06
jurisdictionnot on the record
statuslisted, not haltedsource · 2026-11-08

The disclosure read

The record holds 13 filings in the twelve months to 2026-11-06, across 11 filing days. Filings by type: 12 newswire releases and 1 AGM record date. The median gap between filing days is 14.0 days. The latest filing is a newswire release dated 2026-10-19, 18 days before the record date. Exchange peers (TSX, 2270 issuers): median cadence gap 16 days, median filings 0.0, median latency 3.0 days. Sector peers (Life Sciences, 200 issuers): median cadence gap 17.5 days, median filings 7.0, median latency 14 days.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer131418
exchange median: TSX (2270 issuers)0163
sector median: Life Sciences (200 issuers)717.514
datetypecategoryfiling
2026-10-19newswire_releaseSeraxis and Sernova Announce Appointment of Former FDA
2026-10-05newswire_releaseSernova and Seraxis Close US$11.2 Million Financing to Fund
2026-09-25newswire_releaseSernova Biotherapeutics to Participate in Noble Capital
2026-09-11newswire_releaseSteven Sangha Announces Voting and Support Agreement for Sernova Biotherapeutics Inc.'s Proposed Business Combination with Seraxis Holdings, Inc.
2026-09-10newswire_releaseSernova Biotherapeutics to Participate in the H.C.

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is Ernst & Young LLP; its location is not on the record. The record holds no auditor changes.

Events and halts

The record holds no listing, delisting, name change, domicile change or segment move lines. Halt flag: listed, not halted.

Orderability

Paragraph (o) of the definition: signal ACM-200, determinable. Paragraph (q) of the definition: signal ACM-200, determinable. Rule version acm-68000/ca/kyp-know-your-product-ni-31-103/r1; chapter as of 2026-11-04.

client categoryoutcome
Paragraph (o) of the definitionACM-200
Paragraph (q) of the definitionACM-200

rule acm-68000/ca/kyp-know-your-product-ni-31-103/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

Research-house coverage has not been read.

Open research

Openly published research notes have not been read.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The market's vintage is not sealed. Years sealed in the store but not served as of a date: 2021, 2022, 2023, 2024, 2025, 2026. The as-of door answers not_sealed. The live record began 2026-09-10.

Sources

8 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://www.tsx.com/json/company-directory/search/tsx/^* (identity.exchange)
10.2
https://www.marketscreener.com/quote/stock/SERNOVA-BIOTHERAPEUTICS-I-1411821/news/Sernova-Corp-has-Changed-its-Name-to-Sernova-Biotherapeutics-Inc-48916016 (identity.isin)
10.3
https://www.tsx.com/en/resource/571 (identity.sector)
10.4
https://mcp.ca-cm-kg.ai/events/TSX/SVA (the disclosure lines)
10.5
https://iiroc.mediaroom.com/index.php?s=2429&l=100 (the halt flag)
10.6
https://www.newsfilecorp.com/release/291710/Sernova-Biotherapeutics-Announces-Affirmative-Voting-Results-from-2026-Annual-General-Meeting-of-Shareholders (the auditor)
10.7
https://mcp.ca-cm-kg.ai/book/aio.json (the orderability chapter)
10.8
https://mcp.ca-cm-kg.ai/record/TSX/SVA (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"CA81752F1062"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:ef4e42df18669a3b.